Videos
Engaging the Clinical and Patient DMD Community at the 2025 FUTURES Conference: Heather Medlin, MSW
February 16th 2025The associate vice president of community outreach at CureDuchenne talked about events like the 2025 FUTURES National Conference that aim to bring individuals from the Duchenne community together. [WATCH TIME: 6 minutes]
Understanding the Process Behind Treatment Selection in NMOSD: Tammy Smith, MD, PhD
February 14th 2025The assistant professor in the neurology department at the University of Utah in Salt Lake City provided a clinical overview of the new and old therapies for NMOSD, and how clinicians should go about choosing for their patients. [WATCH TIME: 6 minutes]
Using Integrative Neurology and Personalized Medicine to Transform Care in 2025: Sushma Kola, MD
February 14th 2025The director of Integrative Neurosciences at Allegheny Health Network talked about integrative neurology, personalized medicine, and emerging diagnostic tools that enhance patient-centered care. [WATCH TIME: 5 minutes]
Reducing OFF Time in Parkinson Disease With SPN-830 Infusion Therapy: Julie Pilitsis, MD, PhD, MBA
February 13th 2025The chair of neurosurgery at the University of Arizona talked about the newly approved infusion therapy that offers continuous medication delivery to improve both motor and non-motor symptoms in Parkinson disease. [WATCH TIME: 5 minutes]
Addressing Social Isolation in Narcolepsy and Idiopathic Hypersomnia: Julie Flygare, JD
February 12th 2025The president and CEO at Project Sleep highlighted the need for clinicians to facilitate awareness of patient advocacy resources for those living with narcolepsy or idiopathic hypersomnia. [WATCH TIME: 5 minutes]
Evaluating the Efficacy of Thrombectomy in Distal Vessel Occlusions: J Mocco, MD, MS
February 11th 2025The director of the Cerebrovascular Center at Mount Sinai talked about findings from recent trials presented at ISC 2025 investigating thrombectomy for distal vessel occlusions. [WATCH TIME: 4 minutes]
Evolution of Stroke Treatment on Display at ISC 2025: Andrei Alexandrov, MD
February 10th 2025The professor and chair of the neurology department at the University of Arizonia, Phoenix, gave clinical insights on the notable progress in the stroke treatment world, highlighted by advances presented at the 2025 International Stroke Conference. [WATCH TIME: 3 minutes]
Expanding the Time Window for Intravenous Thrombolysis in Ischemic Stroke: Min Lou MD, PhD
February 10th 2025The professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine discussed findings from a trial suggesting that intravenous thrombolysis could benefit patients with ischemic stroke up to 24 hours after symptom onset. [WATCH TIME: 8 minutes]
Using Practical Training to Enhance Movement Disorder Care: Clarisse Goas MSN, APRN-CNP
February 7th 2025The movement disorders nurse practitioner at The Ohio State University Wexner Medical Center talked about a meeting that equips nurse practitioners and physician assistants to improve movement disorder patient care. [WATCH TIME: 5 minutes]
Mechanism and Promise Behind SPN-830 for Parkinson Disease: Stuart Isaacson, MD, FAAN
February 7th 2025The director of the Parkinson’s Disease and Movement Disorders Center of Boca Roaton, Florida, gave clinical insight on the function of a newly approved therapy for Parkinson disease, a common neurodegenerative disorder. [WATCH TIME: 3 minutes]
Patient Perspective on the Role of Social Support in Managing Narcolepsy: Julie Flygare, JD
February 5th 2025The president and CEO at Project Sleep talked about the foundational role of social connections and peer support in improving quality of life for individuals with narcolepsy. [WATCH TIME: 5 minutes]
Reaction and Significance of SPN-830 Approval for Parkinson Disease: Stuart Isaacson, MD, FAAN
February 5th 2025The director of the Parkinson’s Disease and Movement Disorders Center of Boca Raton, Florida, discussed SPN-830, the first and only FDA-approved subcutaneous apomorphine infusion device for patients with Parkinson disease. [WATCH TIME: 2 minutes]
Medical Insights on the Recent Approval of AXS-07 for Acute Migraine Treatment: Stewart Tepper, MD
February 5th 2025The professor of neurology at the Geisel School of Medicine at Dartmouth shared his reaction to the recent FDA approval of AXS-07, a combination of meloxicam and rizatriptan, as a new therapy for acute migraine management. [WATCH TIME: 4 minutes]
Clinical Perspective on Newly Approved Combination Therapy for Migraine: Richard B. Lipton, MD
February 4th 2025The director of the Montefiore Headache Center at Albert Einstein College of Medicine discussed the recent FDA approval of a new migraine treatment that combines rizatriptan and meloxicam. [WATCH TIME: 5 minutes]
What to Expect at MDA’s 2025 Clinical and Scientific Conference: Barry J. Byrne, MD, PhD
January 30th 2025The chief medical advisor at the Muscular Dystrophy Association shared key highlights of what attendees can expect at the 2025 MDA Clinical and Scientific Conference. [WATCH TIME: 4 minutes]
